- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Briacell Therapeutics Corp (BCT)
Briacell Therapeutics Corp stock price live, this page displays TSX BCT stock exchange data. View the BCT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Briacell Therapeutics Corp real time stock price chart below.
What Is the Briacell Therapeutics Corp Stock Price Today?
The Briacell Therapeutics Corp stock price today is 0.87.
What Is the Stock Symbol for Briacell Therapeutics Corp?
The stock symbol for Briacell Therapeutics Corp is ""BCT.""
What Stock Exchange Does Briacell Therapeutics Corp Trade On?
Briacell Therapeutics Corp is listed and trades on the Toronto stock exchange.
Is Briacell Therapeutics Corp a Good Stock to Buy?
Determining whether Briacell Therapeutics Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BCT quote. (ISIN: CA1079302081)
What Is the Briacell Therapeutics Corp Stock Price Today?
The Briacell Therapeutics Corp stock price today is 0.87.
What Is the Stock Symbol for Briacell Therapeutics Corp?
The stock symbol for Briacell Therapeutics Corp is ""BCT.""
What Stock Exchange Does Briacell Therapeutics Corp Trade On?
Briacell Therapeutics Corp is listed and trades on the Toronto stock exchange.
Is Briacell Therapeutics Corp a Good Stock to Buy?
Determining whether Briacell Therapeutics Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BCT quote. (ISIN: CA1079302081)
0.87
-0.19(-17.92%)
Real-time Data·
Fair Value
An estimate of a Briacell Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.86
1.01
52 wk Range
0.86
37.95
BCT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
1/3
Fair Value
An estimate of a Briacell Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.861.01
52 wk Range
0.8637.95
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BCT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Briacell Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Briacell Therapeutics Corp Company Profile
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
Compare BCT to Peers and Sector
Metrics to compare | BCT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBCTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | −2.1x | −0.5x | |
PEG Ratio | 0.01 | 0.00 | 0.00 | |
Price/Book | 1.1x | −0.2x | 2.6x | |
Price / LTM Sales | - | 5.8x | 3.3x | |
Upside (Analyst Target) | - | 183.7% | 42.8% | |
Fair Value Upside | Unlock | 7.3% | 6.5% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.00
Earnings
Latest Release
Jun 16, 2025
EPS / Forecast
-1.64 / -0.42
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Briacell Therapeutics Trade On?
Briacell Therapeutics is listed and trades on the Toronto Stock Exchange stock exchange.
What Is the Stock Symbol for Briacell Therapeutics?
The stock symbol for Briacell Therapeutics is "BCT."
What Is the Briacell Therapeutics Market Cap?
As of today, Briacell Therapeutics market cap is 15.27M.
What Is Briacell Therapeutics's Earnings Per Share (TTM)?
The Briacell Therapeutics EPS (TTM) is -8.32.
From a Technical Analysis Perspective, Is BCT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Briacell Therapeutics Stock Split?
Briacell Therapeutics has split 3 times.
How Many Employees Does Briacell Therapeutics Have?
Briacell Therapeutics has 16 employees.
What is the current trading status of Briacell Therapeutics (BCT)?
As of 06 Aug 2025, Briacell Therapeutics (BCT) is trading at a price of 0.87, with a previous close of 1.06. The stock has fluctuated within a day range of 0.86 to 1.01, while its 52-week range spans from 0.86 to 37.95.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.